Cargando…

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

BACKGROUND: Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited. METHODS: PPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices...

Descripción completa

Detalles Bibliográficos
Autores principales: Braune, Stefan, Bluemich, Sandra, Bruns, Carola, Dirks, Petra, Hoffmann, Jeanette, Heer, Yanic, Rouzic, Erwan Muros-Le, Bergmann, Arnfin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320981/
https://www.ncbi.nlm.nih.gov/pubmed/37407914
http://dx.doi.org/10.1186/s12883-023-03273-9
_version_ 1785068543625134080
author Braune, Stefan
Bluemich, Sandra
Bruns, Carola
Dirks, Petra
Hoffmann, Jeanette
Heer, Yanic
Rouzic, Erwan Muros-Le
Bergmann, Arnfin
author_facet Braune, Stefan
Bluemich, Sandra
Bruns, Carola
Dirks, Petra
Hoffmann, Jeanette
Heer, Yanic
Rouzic, Erwan Muros-Le
Bergmann, Arnfin
author_sort Braune, Stefan
collection PubMed
description BACKGROUND: Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited. METHODS: PPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices were employed for retrospective cross-sectional and longitudinal analyses. The cross-sectional analysis included a contemporary PPMS cohort with a documented visit within the last 2 years before index date (1 Jan 2021). The longitudinal analysis included a disease modifying therapy (DMT)-naïve population and focused on the evolution of expanded disability status scale (EDSS) from the first available assessment at or after diagnosis within the NTD registry to index date. Outcome measures were estimated median time from first EDSS assessment to first 24-week confirmed EDSS ≥ 4 and ≥ 7. Besides EDSS change, the proportion of patients on disability pension were described over time. RESULTS: The cross-sectional analysis included 481 PPMS patients (59.9% female, mean [standard deviation, SD] age 60.5 [11.5] years, mean [SD] EDSS 4.9 [2.1]). Estimated median time from first EDSS assessment after diagnosis to reach 24-week confirmed EDSS ≥ 4 for DMT-naïve patients was 6.9 years. Median time to EDSS ≥ 7 was 9.7 years for 25% of the population. Over a decade mean (SD) EDSS scores increased from 4.6 (2.1) to 5.7 (2.0); the proportion of patients on disability pension increased from 18.9% to 33.3%. CONCLUSIONS: This study provides first insights into the German NTD real-world cohort of PPMS patients. Findings confirm the steadily deteriorating course of PPMS accompanied by increasingly limited quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-023-03273-9.
format Online
Article
Text
id pubmed-10320981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103209812023-07-06 The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry Braune, Stefan Bluemich, Sandra Bruns, Carola Dirks, Petra Hoffmann, Jeanette Heer, Yanic Rouzic, Erwan Muros-Le Bergmann, Arnfin BMC Neurol Research BACKGROUND: Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited. METHODS: PPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices were employed for retrospective cross-sectional and longitudinal analyses. The cross-sectional analysis included a contemporary PPMS cohort with a documented visit within the last 2 years before index date (1 Jan 2021). The longitudinal analysis included a disease modifying therapy (DMT)-naïve population and focused on the evolution of expanded disability status scale (EDSS) from the first available assessment at or after diagnosis within the NTD registry to index date. Outcome measures were estimated median time from first EDSS assessment to first 24-week confirmed EDSS ≥ 4 and ≥ 7. Besides EDSS change, the proportion of patients on disability pension were described over time. RESULTS: The cross-sectional analysis included 481 PPMS patients (59.9% female, mean [standard deviation, SD] age 60.5 [11.5] years, mean [SD] EDSS 4.9 [2.1]). Estimated median time from first EDSS assessment after diagnosis to reach 24-week confirmed EDSS ≥ 4 for DMT-naïve patients was 6.9 years. Median time to EDSS ≥ 7 was 9.7 years for 25% of the population. Over a decade mean (SD) EDSS scores increased from 4.6 (2.1) to 5.7 (2.0); the proportion of patients on disability pension increased from 18.9% to 33.3%. CONCLUSIONS: This study provides first insights into the German NTD real-world cohort of PPMS patients. Findings confirm the steadily deteriorating course of PPMS accompanied by increasingly limited quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-023-03273-9. BioMed Central 2023-07-05 /pmc/articles/PMC10320981/ /pubmed/37407914 http://dx.doi.org/10.1186/s12883-023-03273-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Braune, Stefan
Bluemich, Sandra
Bruns, Carola
Dirks, Petra
Hoffmann, Jeanette
Heer, Yanic
Rouzic, Erwan Muros-Le
Bergmann, Arnfin
The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title_full The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title_fullStr The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title_full_unstemmed The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title_short The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
title_sort natural history of primary progressive multiple sclerosis: insights from the german neurotransdata registry
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320981/
https://www.ncbi.nlm.nih.gov/pubmed/37407914
http://dx.doi.org/10.1186/s12883-023-03273-9
work_keys_str_mv AT braunestefan thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT bluemichsandra thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT brunscarola thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT dirkspetra thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT hoffmannjeanette thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT heeryanic thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT rouzicerwanmurosle thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT bergmannarnfin thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT thenaturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT braunestefan naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT bluemichsandra naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT brunscarola naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT dirkspetra naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT hoffmannjeanette naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT heeryanic naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT rouzicerwanmurosle naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT bergmannarnfin naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry
AT naturalhistoryofprimaryprogressivemultiplesclerosisinsightsfromthegermanneurotransdataregistry